Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Raquel Arias Gonzalez

Raquel Arias Gonzalez

Institutions of which they are part

Kidney Physiopathology
Vall Hebron Institut de Recerca
Raquel Arias Gonzalez

Raquel Arias Gonzalez

Raquel Arias Gonzalez

Institutions of which they are part

Kidney Physiopathology
Vall Hebron Institut de Recerca

Projects

Grup de Recerca en Malalties Neurovasculars

IP: Joan Montaner Villalonga
Collaborators: Raquel Arias Gonzalez, José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Anna Rosell Novel, Manuel Quintana Luque
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 46800
Reference: 2009 SGR 432
Duration: 01/01/2010 - 30/04/2014

Identificación y uso de biomarcadores pronósticos en el ictus isquémico

IP: Joan Montaner Villalonga
Collaborators: Raquel Arias Gonzalez, Anna Penalba Morenilla, Olga Maisterra Santos
Funding agency: Instituto de Salud Carlos III
Funding: 228690
Reference: PI080361
Duration: 01/01/2009 - 31/12/2011

GRECOS Project: Genotyping Recurrence risk Of Stroke

IP: Joan Montaner Villalonga
Collaborators: Raquel Arias Gonzalez, Manuel Quintana Luque
Funding agency: Fundació La Marató de TV3
Funding: 198662
Reference: TV3/062610
Duration: 01/01/2007 - 31/10/2010

Related news

Attendees and speakers at the 8th Conference on Hereditary Hypomagnesemias

The 8th conference on hereditary hypomagnesemia strengthens research collaboration

The event, held at the VHIR Main Building, marked more than a decade of collaboration between the Institute and the HIPOFAM association and included a co-creation session to identify challenges and needs among patients and professionals.

Dr. Gerard Cantero-Recasens

Dr. Cantero-Recasens receives an award to create a new model to study Dent disease

The Oliver Wrong Research Award, granted by the Dent Disease Foundation, will fund a project combining kidney organoids and artificial intelligence to identify potential treatments for this rare kidney disease.

Equip del grup de Fisiopatologia Renal del VHIR

Vall d’Hebron identifies a new mechanism related to the variability of Dent disease

The team has discovered that a protein called SEC22B acts as a phenotype modifier and could be used as a potential urinary marker of the disease.

See more

Related professionals

Juan Manuel Pericas Pulido

Juan Manuel Pericas Pulido

Director/a Àrea
Commercial and Academic Clinical Research
Read more
Nuria Martínez Royuela

Nuria Martínez Royuela

Administration and Management
Clinical Neuroimmunology
Read more
Anna Santamaria Margalef

Anna Santamaria Margalef

Director/a Àrea
Internal Strategy Directorate
Read more
Laura Gonzalez Garcia

Laura Gonzalez Garcia

Growth and Development
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.